BNTX
BioNTech SE
BNTX trails on the overall score without a compensating advantage in the available component scores.
UNH
UnitedHealth Group Incorporated
UNH has the edge over BNTX overall, supported by stronger modeled upside and stronger fundamentals.
BNTX Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Strong | |
| Strong |
BNTX's cash flow and balance sheet are currently strong, but its revenue and profitability are under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
BNTX PE Valuation
BNTX has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
BNTX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| -- | |
| Limited | |
| Low |
Analysts expect BNTX's losses to grow, with revenue declining. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
BNTX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$7.48 | -$5.88 |
| Q1 2026 | -$5.65 | -$2.03 |
| Q4 2025 | -$5.20 | -$2.05 |
| Q3 2025 | -$2.63 | -$0.32 |
| Q2 2025 | -$1.60 | +$0.84 |
| Q1 2025 | -$3.62 | -854% |
| Q4 2024 | -$3.15 | -175% |
| Q3 2024 | -$2.31 | -119% |
BNTX lost $7.48 per share over the past year, and its loss has widened in each of the last four quarters.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over BNTX on earnings quality, reporting a profit while its opponent remains loss making.
BNTX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $117.3M | -60% |
| Q1 2026 | $133.4M | -34% |
| Q4 2025 | $998.6M | -24% |
| Q3 2025 | $1.7B | +22% |
| Q2 2025 | $289.7M | +103% |
| Q1 2025 | $203.1M | -2.6% |
| Q4 2024 | $1.3B | -20% |
| Q3 2024 | $1.4B | +39% |
BNTX's revenue has slid since its 2022 peak: $117M last quarter, down 60% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -898% | -706 points |
| Q1 2026 | -560% | -268 points |
| Q4 2025 | -26% | -38 points |
| Q3 2025 | -3.1% | -3.9 points |
| Q2 2025 | -192% | +559 points |
| Q1 2025 | -292% | -22 points |
| Q4 2024 | 12% | -23 points |
| Q3 2024 | 0.8% | -7.3 points |
BNTX's operating margin was −898% last quarter, down 706 points from the same quarter a year ago, near the bottom of its range since 2019.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over BNTX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over BNTX on profitability, with a higher operating margin.
BNTX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$49.8M | -106% |
| Q1 2026 | -$539.5M | +$1.1B |
| Q4 2025 | $264M | +$932.4M |
| Q3 2025 | $901.1M | +$1.8B |
| Q2 2025 | $777.7M | -56% |
| Q1 2025 | -$1.6B | -$1.1B |
| Q4 2024 | -$668.4M | -153% |
| Q3 2024 | -$865.1M | -218% |
BNTX's free cash flow has turned positive again: $576M over the past year, against −$2.4B the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over BNTX on cash flow, with more consistent year-over-year improvement.
BNTX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +449K shares |
| 1 year | +4.8% | +11.7M shares |
| 3 years | +5.7% | +13.6M shares |
| 5 years | -2.1% | -5.5M shares |
| Available history | +10% | +23.9M shares |
BNTX has 253M diluted shares, up 4.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $146.7M |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BNTX spent $147M buying back its own shares over the past year, after none the year before.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over BNTX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
BNTX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2024 | -149.4x | Net Cash |
| Q4 2023 | -10.3x | Net Cash |
| Q3 2023 | -3.4x | Net Cash |
| Q2 2023 | -2.3x | Net Cash |
| Q1 2023 | -1.5x | Net Cash |
| Q4 2022 | -1.0x | Net Cash |
| Q3 2022 | -0.9x | Net Cash |
| Q2 2022 | -0.5x | Net Cash |
BNTX has more cash than debt.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
BNTX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.6 | Neutral |
| Stochastic | 5.7 | Oversold |
BNTX's weekly RSI is 41 (neutral) and its Stochastic is 6 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
BNTX PE vs Healthcare Sector
| Metric | BNTX | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
BNTX has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
BNTX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $91.1 | 6.7% below |
| 20 week MA | $94.6 | 10% below |
| 50 week MA | $96.6 | 12% below |
| 100 week MA | $101.4 | 16% below |
| 200 week MA | $103.6 | 18% below |
BNTX is in a downtrend: it's below all five of its weekly moving averages, and 18% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over BNTX on trend strength, trading above more of its moving averages.
BNTX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $32.6 | $97.0 | +198% |
| 2021 | $97.0 | $255.3 | +163% |
| 2022 | $255.3 | $176.0 | -31% |
| 2023 | $176.0 | $105.5 | -40% |
| 2024 | $105.5 | $114.0 | +8% |
| 2025 | $114.0 | $94.5 | -17% |
| 2026 YTD | $94.5 | $85.0 | -10% |
BNTX's yearly returns have swung widely, from +198% in 2020 to −40% in 2023. It's down 10% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over BNTX on returns for 2026, with the stronger performance.